Research has shown that psychosocial treatments, such as cognitive-behavioural therapy, can reduce symptoms and improve overall well-being of people who are experiencing a first psychotic episode. Yet, studies also show that only about one-third of potential candidates for treatment agree to participate in and complete the therapy. Dr. Tania Lecomte is exploring why some individuals experiencing a first psychotic episode refuse or fail to adhere to treatment. Besides assessing whether or not motivation enhancement therapy improves adherence to treatment, she is also evaluating the impact on symptoms and patient well-being when they receive both motivation therapy and cognitive-behavioural therapy, or just the latter. If motivation therapy is shown to be effective, results from the study could help young people cope better with psychotic symptoms. Her research may also reveal new information about factors that motivate individuals with psychotic symptoms to seek help.